Immunotherapy for HPV Malignancies.

Abstract:

:Owing to the presence of known tumor-specific viral antigens, human papillomavirus (HPV)-associated cancers are well suited for treatment with immunotherapy designed to unleash, amplify or replace the T cell arm of the adaptive immune system. Immune checkpoint blockade designed to unleash existing T cell immunity is currently Food and Drug Administration approved for certain HPV-associated cancers. More specific immunotherapies such as therapeutic vaccines and T cell receptor-engineered cellular therapy are currently in clinical development. Such therapies may offer more specific immune activation against viral tumor antigens and decrease the risk of immune-related adverse events. Current and planned clinical study of these treatments will determine their utility in the treatment of patients with newly diagnosed advanced stage or relapsed HPV-associated cancer.

journal_name

Semin Radiat Oncol

authors

Lee MY,Allen CT

doi

10.1016/j.semradonc.2021.02.008

subject

Has Abstract

pub_date

2021-10-01 00:00:00

pages

361-370

issue

4

eissn

1053-4296

issn

1532-9461

pii

S1053-4296(21)00016-3

journal_volume

31

pub_type

杂志文章,评审
  • Endovascular brachytherapy for peripheral vascular disease.

    abstract::The most common cause of morbidity and mortality in the United States is vascular disease, which afflicts a wide spectrum of organs such as the heart (cardiovascular system), brain (cerebrovascular system), kidney (renal system), liver (hepatic system), and extremities (peripheral vascular system). The most common pat...

    journal_title:Seminars in radiation oncology

    pub_type: 杂志文章,评审

    doi:10.1016/s1053-4296(99)80009-5

    authors: Tripuraneni P,Giap H,Jani S

    更新日期:1999-04-01 00:00:00

  • Clinical and financial issues for intensity-modulated radiation therapy delivery.

    abstract::Intensity-modulated radiation therapy (IMRT) is a term applied to a new technology that uses nonuniform radiation beams to achieve conformal dose distributions. This article reviews the use of a commercial system, the Peacock system, which uses a special multileaf collimator (MIMiC) to deliver the dose distribution us...

    journal_title:Seminars in radiation oncology

    pub_type: 杂志文章,评审

    doi:10.1016/s1053-4296(99)80057-5

    authors: Grant W 3rd,Woo SY

    更新日期:1999-01-01 00:00:00

  • Chemoradiotherapy for advanced inoperable head and neck cancer: A phase II study.

    abstract::The beneficial effects of chemotherapy in patients with advanced head and neck cancer remain controversial in terms of survival, but have shown some promise in improving locoregional control and quality of life. In an effort to improve locoregional control and survival, a prospective phase II study was initiated using...

    journal_title:Seminars in radiation oncology

    pub_type: 临床试验,杂志文章

    doi:

    authors: Chougule PB,Akhtar MS,Akerley W,Ready N,Safran H,McRae R,Nigri P,Bellino J,Koness J,Radie-Keane K,Wanebo H

    更新日期:1999-04-01 00:00:00

  • A pilot clinical laboratory trial of paclitaxel and endobronchial brachytherapy in patients with non-small cell lung cancer.

    abstract::Paclitaxel enhances microtubule assembly and causes a cell cycle arrest in mitosis, the most radiosensitive phase. We conducted this study to improve our understanding of paclitaxel effects in vivo and to determine the maximum tolerated dose of paclitaxel preceding endobronchial radiation therapy (brachytherapy). The ...

    journal_title:Seminars in radiation oncology

    pub_type: 临床试验,杂志文章

    doi:

    authors: Lee JS,Komaki R,Morice RC,Ro JY,Kalapurakal SK,Schea R,Murphy WK,Shin DM,Fox NT,Walsh GL,Hittelman WN,Hong WK

    更新日期:1999-04-01 00:00:00

  • Postmastectomy radiation in patients with one to three positive axillary nodes receiving adjuvant chemotherapy: An unresolved issue.

    abstract::The rationale for postmastectomy radiation is based on the prevention of locoregional recurrence in the chest wall, regional lymphatics, or both. The randomized trials of postmastectomy radiation in patients with one to three positive nodes receiving adjuvant chemotherapy have shown a proportional reduction in locoreg...

    journal_title:Seminars in radiation oncology

    pub_type: 杂志文章,评审

    doi:10.1016/s1053-4296(99)80014-9

    authors: Fowble B

    更新日期:1999-07-01 00:00:00

  • Evidence for using adjuvant chemotherapy as standard treatment of soft tissue sarcoma.

    abstract::The role of adjuvant chemotherapy in the treatment of patients with soft-tissue sarcomas remains controversial. The initial observation that extremity tumors might benefit more than tumors of other primary sites prompted careful review of published data. Eight of 9 studies showed improved disease-free and overall surv...

    journal_title:Seminars in radiation oncology

    pub_type: 杂志文章,meta分析

    doi:10.1016/s1053-4296(99)80028-9

    authors: Benjamin RS

    更新日期:1999-10-01 00:00:00

  • Role of Postradical Prostatectomy Irradiation in Carcinoma of the Prostate.

    abstract::The indications and results of postradical prostatectomy adjuvant pelvic radiation therapy (6,000 to 6,500 cGy) are reviewed. In patients with positive with positive surgical margins, 80% to 100% local tumor control has been reported; in 42 patients treated at our institution, the 5-year actuarial tumor control rate w...

    journal_title:Seminars in radiation oncology

    pub_type: 杂志文章

    doi:10.1053/SRAO00300198

    authors: Perez CA,Eisbruch A

    更新日期:1993-07-01 00:00:00

  • Plan Optimization and Dose Evaluation in Brachytherapy.

    abstract::Today's imaging and computer technology has made significant advances in brachytherapy optimization and evaluation possible. Optimization may be of source strength or of source position (or both). An objective function of achieved versus desired doses is minimized, a global minimum being associated with an analytic so...

    journal_title:Seminars in radiation oncology

    pub_type: 杂志文章

    doi:10.1053/SRAO00300290

    authors: Anderson LL

    更新日期:1993-10-01 00:00:00

  • Current Issues in the Staging of Esophageal Cancer.

    abstract::Staging technology and the 1983 international staging system for esophageal cancer have changed. The 1988 system is based on depth of wall penetration and regional lymph node involvement; it abandons the previous criteria of tumor length and degree of obstruction. The clinical reasoning behind this change is reviewed....

    journal_title:Seminars in radiation oncology

    pub_type: 杂志文章

    doi:10.1053/SRAO00400135

    authors: Jaklitsch MT,Harpole DH Jr,Healey EA,Sugarbaker DJ

    更新日期:1994-07-01 00:00:00

  • Results of Concomitantly Administered Chemoradiation for Locally Advanced Noninflammatory Breast Cancer.

    abstract::Locally advanced breast cancer patients are a heterogeneous group with a wide range of prognoses. They require a multimodality approach to the treatment of their illness with the interdigitation of surgery, chemotherapy, and radiation therapy. Systemic, chemotherapy has gained widespread acceptance for the treatment o...

    journal_title:Seminars in radiation oncology

    pub_type: 杂志文章

    doi:10.1053/SRAO00400226

    authors: Berg CD,Swain SM

    更新日期:1994-10-01 00:00:00

  • The Value of Anatomic Staging and Other Prognostic Factors in Small Cell Lung Cancer Management: A View of European Studies.

    abstract::The need to include simple laboratory indices and performance status evaluation in treatment decision making has been shown by multivariate analyses. The conventional limited-stage extensive-stage division of prognostic groups no longer provides sufficient information. Indeed, some patients in the limited-stage group ...

    journal_title:Seminars in radiation oncology

    pub_type: 杂志文章

    doi:10.1054/SRAO00500019

    authors: Thatcher N,Anderson H,Burt P,Stout R

    更新日期:1995-01-01 00:00:00

  • Computer-Controlled Treatment Delivery.

    abstract::Computer-controlled treatment machines and the delivery of conformal radiotherapy treatments using computer-controlled and/or automated delivery techniques have become an important new area of clinical and research activity in recent years. The historical experience with simple multileaf collimators and control system...

    journal_title:Seminars in radiation oncology

    pub_type: 杂志文章

    doi:10.1054/SRAO00500077

    authors: Fraass BA,McShan DL,Kessler ML

    更新日期:1995-04-01 00:00:00

  • Radiobiophysical Aspects of Stereotaxic Radiation Treatment of Central Nervous System Diseases.

    abstract::The biophysical aspects of stereotaxic treatment are summarized, emphasizing the complex interplay between time-dose-fractionation, partial volume effect, physical dose distribution, and set-up uncertainties in influencing treatment outcome. The radiobiological advantage of dose-fractionation for normal tissue sparing...

    journal_title:Seminars in radiation oncology

    pub_type: 杂志文章

    doi:10.1054/SRAO00500192

    authors: Ling CC,Lo YC,Larson DA

    更新日期:1995-07-01 00:00:00

  • The Large-Cell Lymphomas.

    abstract::Diffuse large-cell and immunoblastic lymphoma (DLCL), considered together, are the most common histologic subtypes of non-Hodgkin's lymphoma (NHL). There will be approximately 15,500 new cases of DLCL in 1995 and this represents a dramatic increase over the last 20 years. The cause of KLCL is unknown, but its associat...

    journal_title:Seminars in radiation oncology

    pub_type: 杂志文章

    doi:10.1054/SRAO00500267

    authors: Shafman TD,Mauch PM

    更新日期:1995-10-01 00:00:00

  • Hypoxic Stress Proteins: Survival of the Fittest.

    abstract::The importance of tumor microenvironmental in malignant progression has been largely ignored. Tumor cells protect themselves from changes in the microenvironment due to a decrease in nutrients and oxygen by reducing macromolecular synthesis and inducing genes that will promote angiogenesis and tissue remodeling. This ...

    journal_title:Seminars in radiation oncology

    pub_type: 杂志文章

    doi:10.1053/SRAO0060046

    authors: Giaccia AJ

    更新日期:1996-01-01 00:00:00

  • RAPID: An Electronic Medical Records System for Radiation Oncology.

    abstract::A electronic text-based medical record system used in a radiation oncology department since 1990 is described. The database is composed of a group of subfiles linked with a powerful relational database. The clinically relevant subfile structures are described and the hardware and software requirements for the system a...

    journal_title:Seminars in radiation oncology

    pub_type: 杂志文章

    doi:10.1053/SRAO00700004

    authors: Sailer SL,Tepper JE,Margolese-Malin L,Rosenman JG,Chaney EL

    更新日期:1997-01-01 00:00:00

  • 1996 Decision Trees and Management Guidelines.

    abstract::The starting Point for quality assessment for the Patterns of Care Study is to establish by consensus the current management guidelines for each site. This article presents decision trees, recommended treatment systems, and brief summaries of the guidelines developed for cancer of the esophagus, rectum, anus, breast, ...

    journal_title:Seminars in radiation oncology

    pub_type: 杂志文章

    doi:10.1053/SRAO00700163

    authors:

    更新日期:1997-04-01 00:00:00

  • An Approach to Radiosensitizing Cervical Cancer by Use of Chemical Modulators of Nucleoside Metabolism.

    abstract::Although radiation alone is the treatment of choice for patients with cervical cancer that is not surgically respectable, locoregional failures rates approach 50% for locally advanced stages of disease. Therefore, decades of clinical trials using chemoradiotherapy have been performed in an attempt to enhance cure rate...

    journal_title:Seminars in radiation oncology

    pub_type: 杂志文章

    doi:10.1053/SRAO00700324

    authors: Petereit DG,Kinsella TJ

    更新日期:1997-10-01 00:00:00

  • Internal dosimetry for systemic radiation therapy.

    abstract::The key to effective use of the medical internal radiation dose (MIRD) schema in radioimmunotherapy (RIT) is to understand how it works and what the essential data input requirements are. The fundamental data are acquired from medical imaging. Image interpretation involves (1) collecting data to determine the source-o...

    journal_title:Seminars in radiation oncology

    pub_type: 杂志文章,评审

    doi:10.1016/s1053-4296(00)80049-1

    authors: Fisher DR

    更新日期:2000-04-01 00:00:00

  • Tissue tolerance to reirradiation.

    abstract::There are increasing requests for delivering a second course of radiation to patients who develop second primary tumors within or close to previous radiotherapy portal or late in-field recurrences. Rational treatment decisions demand rather precise knowledge on long-term recovery of occult radiation injury in various ...

    journal_title:Seminars in radiation oncology

    pub_type: 杂志文章,评审

    doi:10.1053/srao.2000.6593

    authors: Nieder C,Milas L,Ang KK

    更新日期:2000-07-01 00:00:00

  • Point: the potential importance of elective nodal irradiation in the treatment of non-small cell lung cancer.

    abstract::Patients who receive radiation therapy for non-small cell lung cancer (NSCLC) will require accurate targeting of the grossly involved primary and nodal disease. However, the treatment of grossly uninvolved elective nodal sites that may harbor microscopic occult disease is controversial. In simple terms, physicians are...

    journal_title:Seminars in radiation oncology

    pub_type: 评论,杂志文章,评审

    doi:10.1053/srao.2000.9279

    authors: Liengswangwong V,Bonner JA

    更新日期:2000-10-01 00:00:00

  • In vivo imaging of gene expression.

    abstract::Imaging of gene expression is increasingly essential for cancer diagnosis, prediction of tumor response to various available therapies, and for monitoring response to therapy, whether it is gene or nongene therapy. Most of the work on developing techniques and methodologies for imaging gene expression has been perform...

    journal_title:Seminars in radiation oncology

    pub_type: 杂志文章,评审

    doi:10.1053/srao.2001.18102

    authors: Sullivan DC,Hoffman JM

    更新日期:2001-01-01 00:00:00

  • Chemotherapy of low-grade gliomas.

    abstract::Histologic subtypes of low-grade gliomas include pilocytic astrocytomas (World Health Organization [WHO] grade I), diffuse infiltrating astrocytomas, oligodendrogliomas, and mixed oligo-astrocytomas (WHO grade II). Although extended survival is typical with these tumors, most patients eventually succumb to recurrent o...

    journal_title:Seminars in radiation oncology

    pub_type: 杂志文章,评审

    doi:10.1053/srao.2001.21422

    authors: Lesser GJ

    更新日期:2001-04-01 00:00:00

  • Partial irradiation of the liver.

    abstract::The use of three-dimensional radiotherapy (RT) and the prospective follow-up of patients for radiation-induced liver disease (RILD) have led to a more quantitative understanding of the partial organ tolerance of the liver compared with previous estimates based on clinical judgment alone. Parameters of both the Lyman n...

    journal_title:Seminars in radiation oncology

    pub_type: 杂志文章,评审

    doi:10.1053/srao.2001.23485

    authors: Dawson LA,Ten Haken RK,Lawrence TS

    更新日期:2001-07-01 00:00:00

  • Gynecologic brachytherapy-II: Intravaginal brachytherapy for carcinoma of the endometrium.

    abstract::Brachytherapy plays a significant role in the management of endometrial cancer. In the adjuvant setting, based on pathologic risk factors, intravaginal brachytherapy alone, external radiation therapy alone, or a combination of the two is recommended. For patients who are medically inoperable, brachytherapy with or wit...

    journal_title:Seminars in radiation oncology

    pub_type: 杂志文章,评审

    doi:10.1053/srao.2002.28665

    authors: Chadha M

    更新日期:2002-01-01 00:00:00

  • Radiation pneumonitis and early circulatory cytokine markers.

    abstract::Radiation pneumonitis is a distinct clinical entity that differs from other pulmonary symptoms such as allergic pneumonitis, chemical pneumonitis, or pneumonia by various infectious agents. Recent research has supported the mechanism of cellular interaction between lung parenchymal cells and circulating immune cells m...

    journal_title:Seminars in radiation oncology

    pub_type: 杂志文章

    doi:10.1053/srao.2002.31360

    authors: Chen Y,Williams J,Ding I,Hernady E,Liu W,Smudzin T,Finkelstein JN,Rubin P,Okunieff P

    更新日期:2002-01-01 00:00:00

  • Rationale for a phase I/II radiation dose-escalation study with concurrent amifostine (Ethyol) and infusional 5-FU chemotherapy for preoperative treatment of unresectable or locally recurrent rectal carcinoma.

    abstract::Rectal adenocarcinoma almost invariably requires extirpative surgery to be cured. Although radiation therapy and concurrent chemotherapy often will elicit dramatic responses, the treatment morbidity limits the tolerable dose of radiation to about 45 to 50 Gy. Strategies to reduce procto/enteritis may permit higher dos...

    journal_title:Seminars in radiation oncology

    pub_type: 杂志文章

    doi:10.1053/srao.2002.31380

    authors: Myerson R

    更新日期:2002-01-01 00:00:00

  • Clinical application of intensity-modulated radiotherapy for locally advanced cervical cancer.

    abstract::Intensity-modulated radiotherapy (IMRT) offers technical advantages over conventional external beam radiotherapy (CXRT) that might prove clinically advantageous in the management of gynecologic malignancies. Especially in the case of locally advanced cervical cancer, IMRT provides an opportunity to improve the therape...

    journal_title:Seminars in radiation oncology

    pub_type: 杂志文章,评审

    doi:10.1053/srao.2002.32471

    authors: Kavanagh BD,Schefter TE,Wu Q,Tong S,Newman F,Arnfield M,Benedict SH,McCourt S,Mohan R

    更新日期:2002-07-01 00:00:00

  • Epidermal growth factor receptor modulation of radiation response: preclinical and clinical development.

    abstract::Approximately two thirds of all human solid tumors derive from epithelial tissues. The epidermal growth factor receptor (EGFR) serves as an important regulator of cellular growth in epithelial tumors. A spectrum of new anticancer agents have been specifically designed to target the EGFR in an effort to inhibit maligna...

    journal_title:Seminars in radiation oncology

    pub_type: 杂志文章,评审

    doi:10.1053/srao.2002.34865

    authors: Harari PM,Huang SM

    更新日期:2002-07-01 00:00:00

  • Molecular and genetic markers in the local-regional management of breast cancer.

    abstract::The clinical application of molecular markers in the diagnosis, staging, and management of breast cancer continues to expand. Although the use of molecular markers in local-regional disease does not approach the level of their application in the systemic management of breast cancer, a growing body of rature supports t...

    journal_title:Seminars in radiation oncology

    pub_type: 杂志文章,评审

    doi:10.1053/srao.2002.35252

    authors: Haffty BG

    更新日期:2002-10-01 00:00:00